• Home
• Kilas Global
• Jacobson Pharma Launches Smartfish Health Nutrition Products from Norway in Greater China and Asia Pacific Region

Rabu, 13 November 2019 23:00:00

Jacobson Pharma Launches Smartfish Health Nutrition Products from Norway in Greater China and Asia Pacific Region

HONG KONG, RIAUONE.com - 12 November 2019 - Jacobson Pharma Corporation Limited ("Jacobson Pharma" or the  "Group"; Stock Code: 2633), a leading company engaging in research, development, production, marketing and sale of generic drugs and proprietary medicines, announced the launch of Smartfish's health nutrition range of products in Greater China (including Mainland China, Hong Kong, Macau and Taiwan) and Asia under an exclusive distribution agreement with Smartfish AS, a branded health nutrition company incorporated in Norway.
 
According to the agreement, the Group has an in-licensed right for 10 years to distribute and market Smartfish's  consumer health products in Greater China and the Asia Pacific Region, covering four product ranges, namely "Smartfish Recharge" for sports nutrition, "Smartfish Resolve" for improving metabolic health and diabetes care, "Smartfish Reflect" for promoting adults' brain health and cognitive function, and "Smartfish Cream" for benefiting children's brain development
 
Built upon a patented emulsion technology and clinically substantiated, Smartfish's Omega-3-enhanced nutritional drinks and emulsion products complement the fast-growing medical and consumer nutrition markets with products of evidence-based health benefits.
 
Differentiated from standard fish oil supplements, Smartfish's emulsion carries high levels of Omega 3 fatty acids, in synergy with other nutrients, that can produce the potentiating anti-inflammatory effects to deliver various health benefits . It can also ensure a tasty delivery of nutrients by protecting Omega-3 fatty acids, which are rich in fish oil, from oxidizing and forming the rancid taste. The products are clinically tested, and all health benefit claims for Smartfish products are supported by rigorous science.
 
Smartfish's products range provides health nutrition for the elderly and the young, medical nutrition for chronic disease patients, and sports nutrition for athletes. Smartfish has established itself as a trusted nutritional source for professional athletes worldwide being the official supplier of sports nutrition drinks to sports clubs and national teams, which include English Premier League Tottenham Hotspurs Football Club and Norwegian Nordic Combined National Team of Skiing.
 
Jacobson Pharma's strategic collaboration with Smartfish also included a shareholding investment of 9.04% of Smartfish's issued capital made in July 2019, which is expected to forge a stronger partnership and platform for both companies on exploring potential business cooperation in the high growing consumer health nutrition market in the future.
 
Mr. Derek Sum, Chairman and Chief Executive Officer of Jacobson Pharma, comments, "We welcome Smartfish's nutrition products with well-documented potency to our consumer health product portfolio. The  health nutrition market has witnessed strong growth driven by the greater inclination towards self-care and health problems prevention, alongside a growing aged population and increase in disposable income.

Through this collaboration, Jacobson Pharma has primed itself to collaborate with Smartfish in exploiting the latent demand for clinically substantiated health nutrition products to meet different lifestyle and healthcare needs among consumers in Greater China and the Asia Pacific Region."(roc/red/*) #for information on collaboration publications, questions and other e-mails riauonemedia@gmail.com
RIAUONE.com

4 tahun lalu

Jacobson Pharma Announces FY2020 Interim Results

Profit Attributable to Shareholders Lifted by 30.5%
Portfolio and Market Expansion to Harness Growth Potentials
 
HONG KONG, - 26 November 2019 - Jacobson Pharma C

5 tahun lalu

Jacobson Pharma Announces FY2019 Annual Results

Profit Attributable to Shareholders Increased by 23.9% to a Record High of HK$250.6 Million; Total Dividend Up 18.4% to HK4.5 Cents per Share

HONG KONG, CHINA, - 25 June 2

5 tahun lalu

Jacobson Pharma and Yunnan Baiyao Group to Continue Exploring Further Possibilities of Business Cooperation and Other Collaborations

HONG KONG, CHINA, - 8 May 2019 - Jacobson Pharma Corporation Limited ("Jacobson Pharma" or the "Group"; Stock Code: 2633), a leading company engaging in the research, developmen

6 tahun lalu

Jacobson Pharma Announces FY2019 Interim Results

Profit from Operations Leapt by 40.7% to HK$158.6 Million

Declares Interim Dividend of HK1.5 cents per share

Growth Strategies to Tap Innovative Pharma Market and Ex